Overview

Safety and Pharmacology Study of BMS-866949

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether multiple doses.of BMS-886949 are safe and tolerable
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb